The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Improved Biomarkers and Clinical Outcome Measures, 2018Searching for Signs of Parkinson's Disease in the Eye
Study Rationale:
Alpha-synuclein is a protein that clumps in the brains of people with Parkinson's disease (PD). These clumps have also been found in the brain and, recently, the retina -- the back of... -
Target Advancement Program, 2018The Role of Lysosomal Lipid Metabolism in Parkinson's Disease
Study Rationale:
Lysosomes -- tiny bubbles inside the cell responsible for disposing of its waste -- don't work as they should in brain cells of people with Parkinson's disease (PD). Lysosomes are... -
Mitochondrial Biomarkers Program, 2018Mitochondrial DNA Damage in a Pesticide-exposed Cohort
Study Rationale:
Environmental poisons may cause or contribute to some cases of Parkinson’s disease (PD). Mitochondrial impairment is seen in all forms of PD. Some environmental exposures, such as... -
Improved Biomarkers and Clinical Outcome Measures, 2018Cognitive-driven Activities of Daily Living Impairment as a Predictor for Parkinson's Disease Dementia
Study Rationale:
Mild cognitive impairment in Parkinson's disease (PD-MCI) is the highest risk factor for Parkinson's disease dementia (PDD). The core feature for differentiating PDD from PD-MCI is... -
Therapeutic Pipeline Program, 2018The PERSPECTIVE study: Personalized Speech Therapy for Active Conversation
Study Rationale:
Many people with Parkinson's disease have speech problems, which can be overcome by instructing patients to intentionally speak louder. However, to use this technique in daily life... -
Inflammation Biomarkers Program, 2018Studying Age-related Chronic Inflammation in Parkinson's Disease
Study Rationale:
Aging increases the risk of Parkinson's disease (PD), making the disease more likely to occur at an older age. It is unclear how biological changes that accompany normal aging are...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.